Clinical Trial Update: A Single Dose, Open-Label, Dose-escalation Study of the Safety and Imaging Characteristics of LS301-IT for Intraoperative Imaging of Lung Cancer [Phase 1]

View source ↗

Summary

This update describes a Phase 1, dose-escalation study of LS301-IT for intraoperative imaging of lung cancer, focusing on safety and imaging characteristics, wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• LS301-IT

Snippet

Sponsor: Integro Theranostics | Conditions: Lung Cancers | Phase 1 | Status: ACTIVE_NOT_RECRUITING